Previous interest in high-density lipoproteins (HDLs) focused on their possible protective
role in atherosclerotic cardiovascular disease (ASCVD). Evidence from genetic studies and …

High Density Lipoproteins (HDLs) have long been considered as “good cholesterol,”
beneficial to the whole body and, in particular, to cardio-vascular health. However, HDLs are …

Current dyslipidemia management in patients with atherosclerotic cardiovascular disease
(ASCVD) is based on traditional serum lipids. Yet, there is some indication from basic …

Background and objectives Non-alcoholic fatty liver disease (NAFLD) develops due to
impaired hepatic lipid fluxes and is a risk factor for chronic liver disease and atherosclerosis …

High-density lipoprotein (HDL) particles are cholesterol and lipid transport containers.
Mature HDL particles destined for the liver develop through the formation of intermediate …

Inflammatory Bowel Disease (IBD) is characterized by a loss of intestinal barrier function
caused by an aberrant interaction between the immune response and the gut microbiota. In …

Triglyceride-rich lipoproteins (TRLs) are circulating reservoirs of fatty acids used as vital
energy sources for peripheral tissues. Lipoprotein lipase (LPL) is a predominant enzyme …

The transmissible respiratory disease COVID-19, caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has affected millions of people worldwide since its …

Whereas LDL-derived cholesterol accumulates in atherosclerotic lesions, HDL particles are
thought to facilitate removal of cholesterol from the lesions back to the liver thereby …

Abstract Apolipoprotein A1 (ApoA1) is a main protein moiety in high-density lipoprotein
(HDL) particles. Generally, ApoA1 and HDL are considered as atheroprotective. In …